WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Equity

WhiteOak Mutual Fund

Sector - Healthcare

Get the latest NAV of WhiteOak Capital Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹17.28

▲0.4%1D

NAV as on 31 Jul 2026

24.68%/per year

Since Inception

Absolute Gain%

▲▼

1729 people have invested ₹ 1.9Cr in WhiteOak Capital Pharma and Healthcare Fund in the last three months

WhiteOak Capital Pharma and Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (31-Jul-26)

The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.

Period
1M
3M
6M
1Y
3Y
5Y
This Fund
3.92%
16.93%
27.73%
19.04%
--
--
Nifty 500
-0.12%
0.75%
1.22%
-1.9%
10.78%
10.92%
Sector - Healthcare Avg
3.69%
13.99%
22.86%
13.48%
21.41%
14.44%
Best in Sector - Healthcare
5.85%
17.82%
30.71%
20.57%
24.42%
18.21%
Worst in Sector - Healthcare
1.41%
9.37%
16.89%
7.17%
19.59%
12.64%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
3Y Alpha
3Y Beta
3Y Sharpe
3Y Sortino
3Y Info Ratio
WhiteOak Capital Pharma and Healthcare Fund
-
741Cr
0.6%
19.04%
-
--
--
--
--
--
SBI Healthcare Opportunities Fund
1/8
4,998Cr
1.03%
17.46%
24.41%
3.10
0.86
1.17
2.11
0.35
Mirae Asset Healthcare Fund
2/8
3,253Cr
0.44%
16.16%
23.74%
1.06
0.97
1.02
1.83
0.21
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund
3/8
6,625Cr
0.86%
7.17%
24.03%
1.53
0.95
1.04
1.78
0.24
See all

WhiteOak Capital Pharma and Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

WhiteOak Capital Pharma and Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jul-26)

Fund Distribution

as on (14-Jul-26)

Small cap
49.5%
Mid cap
24.4%
Large cap
20.7%
Small Cap allocation has gone up from 47.7% to 52.3%
Small Cap allocation has gone up from 47.7% to 52.3%
Mid Cap allocation has gone down from 23.3% to 18.2%
Mid Cap allocation has gone down from 23.3% to 18.2%
Large Cap allocation has gone up from 22.7% to 23.8%
Large Cap allocation has gone up from 22.7% to 23.8%
Cash allocation has gone up from 0.8% to 0.9%
Cash allocation has gone up from 0.8% to 0.9%

WhiteOak Capital Pharma and Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jul-26)

Sector Allocation

Health
94.2%
Basic Materials
5.8%

Top 3 Sectors in June were Health, Basic Materials & Government

Jun'26

Health

93%

Government

25%

Basic Materials

7%

May'26

Health

92%

Basic Materials

8%

Government

2%

WhiteOak Capital Pharma and Healthcare Fund Holdings Details

as on (30-Jun-26)

Holdings
Weight%
1M Change
Sun Pharmaceuticals Industries Ltd
8.66%
-10.7%
J.B. Chemicals & Pharmaceuticals Ltd
6.94%
-19.5%
Laurus Labs Ltd
4.61%
2.6%
Apollo Hospitals Enterprise Ltd
4.59%
0%
Max Healthcare Institute Ltd Ordinary Shares
4.3%
-8.4%
See all
Top Stocks bought last month
Neuland Laboratories Ltd's allocation increased from 1.42% to 2.64%
Neuland Laboratories Ltd's allocation increased from 1.42% to 2.64%
Rainbow Childrens Medicare Ltd's allocation increased from 0.8% to 1.79%
Rainbow Childrens Medicare Ltd's allocation increased from 0.8% to 1.79%
Poly Medicure Ltd's allocation increased from 0.7% to 1.23%
Poly Medicure Ltd's allocation increased from 0.7% to 1.23%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.35 % to 10.47 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.35 % to 10.47 %
J.B. Chemicals & Pharmaceuticals Ltd's allocation decreased from 8.9 % to 6.54 %
J.B. Chemicals & Pharmaceuticals Ltd's allocation decreased from 8.9 % to 6.54 %
Divi's Laboratories Ltd's allocation decreased from 5.31 % to 4.11 %
Divi's Laboratories Ltd's allocation decreased from 5.31 % to 4.11 %

WhiteOak Capital Pharma and Healthcare Fund Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.6%
Benchmark
BSE Healthcare TR INR
AUM₹741 Cr
Inception Date6 February, 2024
Min Lumpsum/SIP₹500/₹100
Exit Load0%
Lock InNo Lock-in
TurnOver
321.41%
Risk
Risk meter
pointer
Very High Risk

About WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 6 February, 2024. The fund is managed by Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal, Ramesh Mantri. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. WhiteOak Capital Pharma and Healthcare Fund has ₹741 Cr worth of assets under management (AUM) as on Jul 2026 and is more than category average.
  2. The fund has an expense ratio 0.6.

Returns

WhiteOak Capital Pharma and Healthcare Fund has given a CAGR return of 24.68% since inception. Over the last 1 year the fund has given a CAGR return of 19.04%.

Holdings

WhiteOak Capital Pharma and Healthcare Fund has allocated its funds majorly in Health, Cash Equivalent, Government, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, J.B. Chemicals & Pharmaceuticals Ltd, Laurus Labs Ltd, Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd Ordinary Shares

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of WhiteOak Capital Pharma and Healthcare Fund

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 500.00 and for SIP is INR 100.00. WhiteOak Capital Pharma and Healthcare Fund has no lock in period.

Fund Manager

Piyush Baranwal

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund, since 6 February 2024

Dheeresh Pathak

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund, since 6 February 2024

Ashish Agrawal

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund, since 6 January 2025

Trupti Agrawal

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund, since 20 May 2025

Ramesh Mantri

Fund Manager of WhiteOak Capital Pharma and Healthcare Fund, since 6 February 2024

Learn more about WhiteOak Mutual Fund
Parameters
Jun'26
May'26
Apr'26
AUM
₹ 664 Cr
₹ 602.9 Cr
₹ 602.9 Cr
  • AUM of the fund stands at 664 Cr as of Jun'26
  • AUM increased by 61.1 Cr between Jun'26 and May'26

Frequently Asked Questions for WhiteOak Capital Pharma and Healthcare Fund Direct Growth

How do I invest in WhiteOak Capital Pharma and Healthcare Fund?

INDmoney makes it simple to invest in the WhiteOak Capital Pharma and Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘WhiteOak Capital Pharma and Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund?

The NAV of the fund today is ₹17.28. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

WhiteOak Capital Pharma and Healthcare Fund fund has generated a return of 19.04% in 1 year

Who is the fund manager of WhiteOak Capital Pharma and Healthcare Fund?

The fund managers are Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal, Ramesh Mantri.

What is the expense ratio of the fund?

The expense ratio is 0.60%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹741 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of WhiteOak Capital Pharma and Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(8.66%), J.B. Chemicals & Pharmaceuticals Ltd(6.94%), Laurus Labs Ltd(4.61%)